These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


276 related items for PubMed ID: 14962583

  • 21. Intramolecular hydrogen bonding in medicinal chemistry.
    Kuhn B, Mohr P, Stahl M.
    J Med Chem; 2010 Mar 25; 53(6):2601-11. PubMed ID: 20175530
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Applications of solid-state NMR to pharmaceutical polymorphism and related matters.
    Harris RK.
    J Pharm Pharmacol; 2007 Feb 25; 59(2):225-39. PubMed ID: 17270076
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Successful prediction of a model pharmaceutical in the fifth blind test of crystal structure prediction.
    Kazantsev AV, Karamertzanis PG, Adjiman CS, Pantelides CC, Price SL, Galek PT, Day GM, Cruz-Cabeza AJ.
    Int J Pharm; 2011 Oct 14; 418(2):168-78. PubMed ID: 21497184
    [Abstract] [Full Text] [Related]

  • 26. Phase transformation considerations during process development and manufacture of solid oral dosage forms.
    Zhang GG, Law D, Schmitt EA, Qiu Y.
    Adv Drug Deliv Rev; 2004 Feb 23; 56(3):371-90. PubMed ID: 14962587
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Polymorphism in molecular solids: an extraordinary system of red, orange, and yellow crystals.
    Yu L.
    Acc Chem Res; 2010 Sep 21; 43(9):1257-66. PubMed ID: 20560545
    [Abstract] [Full Text] [Related]

  • 29. Computed crystal energy landscapes for understanding and predicting organic crystal structures and polymorphism.
    Price SS.
    Acc Chem Res; 2009 Jan 20; 42(1):117-26. PubMed ID: 18925751
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Modeling the interplay of inter- and intramolecular hydrogen bonding in conformational polymorphs.
    Karamertzanis PG, Day GM, Welch GW, Kendrick J, Leusen FJ, Neumann MA, Price SL.
    J Chem Phys; 2008 Jun 28; 128(24):244708. PubMed ID: 18601366
    [Abstract] [Full Text] [Related]

  • 32. Thermodynamic relationships between nateglinide polymorphs.
    Bruni G, Berbenni V, Milanese C, Girella A, Cardini A, Viganò E, Lanfranconi S, Marini A.
    J Pharm Biomed Anal; 2009 Dec 05; 50(5):764-70. PubMed ID: 19570642
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Impact of solid state properties on developability assessment of drug candidates.
    Huang LF, Tong WQ.
    Adv Drug Deliv Rev; 2004 Feb 23; 56(3):321-34. PubMed ID: 14962584
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Investigation of the phase transitions occurring during and after the dehydration of xylazine hydrochloride monohydrate.
    Krūkle-Bērziņa K, Actiņš A.
    Int J Pharm; 2014 Jul 20; 469(1):40-9. PubMed ID: 24732032
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Predictability of the polymorphs of small organic compounds: crystal structure predictions of four benchmark blind test molecules.
    Chan HC, Kendrick J, Leusen FJ.
    Phys Chem Chem Phys; 2011 Dec 07; 13(45):20361-70. PubMed ID: 21993855
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 14.